Capsular polysaccharide of Streptococcus pneumoniae serotype 12F (CPS12F)

The capsular polysaccharide of Streptococcus pneumoniae serotype 12F is a complex carbohydrate polymer that forms the outermost layer of the bacterium, acting as a critical virulence factor. Its primary biological function is to shield the pathogen from the host's innate immune system by inhibiting complement-mediated opsonization and phagocytosis (Source: PubMed, PMID: 25852161). Serotype 12F is frequently associated with invasive pneumococcal disease (IPD), including bacteremia and meningitis, and has been identified as a common cause of community-acquired pneumonia outbreaks (Source: CDC, Pink Book). In the context of pharmacology, this polysaccharide serves as a key antigenic component in several vaccines, such as the 23-valent pneumococcal polysaccharide vaccine (PPSV23) and the 20-valent pneumococcal conjugate vaccine (PCV20) (Source: FDA, Prevnar 20 Package Insert). These vaccines aim to induce the production of serotype-specific antibodies that facilitate the recognition and destruction of the bacteria by the immune system. Monitoring the prevalence of serotype 12F is essential for evaluating vaccine efficacy and tracking serotype replacement trends in populations (Source: WHO, Pneumococcal Vaccines Position Paper).

Other names

Pneumococcal polysaccharide serotype 12F12F CPSStreptococcus pneumoniae serotype 12F capsular polysaccharideS. pneumoniae serotype 12F antigen

Induction of active immunity through the production of serotype-specific opsonizing antibodies (IgG) that facilitate phagocytosis and killing of the bacteria by host immune cells.